# Diabetic-Retinopathy-Severity-Classification-Using-Deep-Residual-Learning
Automated Diabetic Retinopathy Severity Classification with DeepChem and Deep Residual Learning.

Diabetic retinopathy (DR) is a progressive eye disease caused by complications of diabetes mellitus, posing a significant threat to vision health globally. Early detection and accurate classification of DR severity are crucial for timely intervention and preventing irreversible vision loss. In this research, we propose a deep learning model, named DRModel, for the automated classification of diabetic retinopathy progression using fundus images. Leveraging the rich information captured in high-resolution retina images, our model aims to predict DR severity based on a clinician's rating, graded on a scale of 0 to 4 according to the International Clinical Diabetic Retinopathy Severity Scale. We utilize the APTOS 2019 Blindness Detection dataset, comprising a diverse collection of retina images captured under various imaging conditions.

The DRModel architecture integrates convolutional and fully connected layers, enabling it to extract hierarchical features from raw image data and learn discriminative representations for classification tasks. We employ techniques such as data augmentation and regularization to enhance model robustness and generalization performance. Additionally, we leverage DeepChem, a powerful Python library for deep learning in chemistry and biology, to facilitate the implementation of our proposed solution. Our research contributes to the growing body of literature on deep learning-based approaches for medical image analysis, particularly in the field of diabetic retinopathy diagnosis. We evaluate the performance of the DRModel on benchmark datasets and compare it with existing methodologies, demonstrating its efficacy in accurately classifying diabetic retinopathy severity.

By harnessing the power of deep learning and leveraging large-scale medical image datasets, our research aims to facilitate the development of automated systems for early detection and management of diabetic retinopathy, ultimately improving patient outcomes and reducing the burden on healthcare systems.

